(Q37553880)

21 August 2017

Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience (English)

1 reference

21 August 2017

0 references

1 reference

Eric D Young

6

0 references

Chiara Colombo

Chiara Colombo

7

0 references

Matthew L. Anderson

Matthew L Anderson

13

0 references

Alexander J. Lazar

Alexander J Lazar

11

0 references

Jason L. Hornick

Jason L Hornick

10

0 references

Kelly K Hunt

12

Kelly K Hunt

1 reference

21 August 2017

Kristelle Lusby

1

1 reference

21 August 2017

Kari Brewer Savannah

2

1 reference

21 August 2017

Elizabeth G Demicco

3

1 reference

21 August 2017

Yiqun Zhang

4

1 reference

21 August 2017

Markus Ph Ghadimi

5

1 reference

21 August 2017

Ryan Lam

8

1 reference

21 August 2017

Tugce E Dogan

9

1 reference

21 August 2017

Chad J Creighton

14

1 reference

21 August 2017

Dina Lev

15

1 reference

21 August 2017

Raphael E Pollock

16

1 reference

21 August 2017

20 January 2013

1 reference

Annals of Surgical Oncology

21 August 2017

1 reference

21 August 2017

20

1 reference

21 August 2017

7

1 reference

21 August 2017

2364-2372

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-012-2834-0

21 August 2017

0 references

cites work

Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

New therapeutic targets in soft tissue sarcoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Prognostic factors in uterine sarcoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Trends in survival for patients with metastatic soft-tissue sarcoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

The surgical margin in soft-tissue sarcoma

6 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

6 September 2017

https://api.crossref.org/works/10.1245%2FS10434-012-2834-0

Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

The Prognostic Significance of ‘Stage, Tumor Size, Cellular Atypia and DNA Ploidy in Uterine Leiomyosarcoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

25 June 2018

Sarcomas of the uterus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913478

Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1245%2FS10434-012-2834-0

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis

21 January 2018

1 reference

12 December 2020

Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters

1 reference

12 December 2020

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

1 reference

12 December 2020

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases

1 reference

12 December 2020

The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients

1 reference

12 December 2020

Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas

1 reference

12 December 2020

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas

1 reference

12 December 2020

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma

1 reference

12 December 2020

Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases

1 reference

12 December 2020

10.1245/S10434-012-2834-0

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1033723873

0 references

Fatcat ID

release_zrssv6bbefbnhcurnj5jdimzva

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zrssv6bbefbnhcurnj5jdimzva

24 November 2022

mapped directly with Wikidata item

1 reference

21 August 2017

1 reference